What is the primary objective of **FDA 21 CFR Part 11**?

**FDA 21 CFR Part 11 establishes criteria under which the agency considers electronic records and electronic signatures trustworthy, reliable, and equivalent to paper records and handwritten signatures executed on paper.** Per §11.1(a), it ensures authenticity, integrity, and non-repudiation through controls like validation (§11.10(a)), secure audit trails (§11.10(e)), and signature linking (§11.70). Systems and documentation must be inspection-ready (§11.1(e)).

Who is legally or professionally required to comply with **FDA 21 CFR Part 11**?

**Organizations using electronic records in lieu of paper for predicate rule requirements, relying on electronic records for regulated activities, submitting accepted electronic records to FDA, or using legally binding electronic signatures must comply with FDA 21 CFR Part 11.** Applies to closed (§11.10) and open systems (§11.30); excludes paper records transmitted electronically (§11.1(b)). Predicate rules (e.g., 21 CFR 211, 820) drive scope.

Does **FDA 21 CFR Part 11** require an external audit or third-party certification?

**No, FDA 21 CFR Part 11 does not require external audits or third-party certification.** Compliance is demonstrated through internal validation (§11.10(a)), SOPs, training (§11.10(i)), and inspection readiness (§11.1(e)). FDA's 2003 guidance emphasizes risk-based self-assessment; predicate rules remain enforceable.

How often should an assessment for **FDA 21 CFR Part 11** be performed?

**Assessments for FDA 21 CFR Part 11 should be performed periodically as part of change control, system lifecycle reviews, and prior to FDA inspections, with no fixed frequency mandated in the regulation.** FDA's 2003 guidance supports risk-based periodic reviews; reassess scope upon changes affecting predicate reliance, validation, or controls (§11.10(k)).

What are the consequences of non-compliance with **FDA 21 CFR Part 11**?

**Non-compliance with FDA 21 CFR Part 11 can result in FDA enforcement actions including Form 483 observations, warning letters, product holds, and predicate rule violations.** 2003 guidance notes continued enforcement of access controls (§11.10(d)), signatures (§§11.50-11.300), and predicate requirements; legacy systems lose discretion without documentation.

Can **FDA 21 CFR Part 11** be mapped to other international frameworks?

**Yes, FDA 21 CFR Part 11 controls can be mapped to other frameworks, though the regulation and 2003 guidance focus solely on FDA predicate rules.** Common alignments include electronic record integrity and signatures; organizations document risk-based mappings for global operations.

What is the first step to begin implementing **FDA 21 CFR Part 11**?

**The first step to implement FDA 21 CFR Part 11 is to establish a formal applicability framework mapping predicate rules to records and assessing business reliance on electronic versions.** Per 2003 guidance, document scope decisions in SOPs (e.g., electronic in lieu of paper) before applying controls like §11.10 closed-system safeguards.

Who is legally or professionally required to comply with **WELL**?

**WELL is voluntary and not legally mandated for any organization.** It applies to building owners, developers, operators, and tenants pursuing certification for new/existing buildings via pathways like WELL Certification (owner-controlled), WELL Core (multi-tenant base buildings), or WELL for Residential, targeting real estate executives, facilities managers, and ESG leaders seeking verified health outcomes.

Does **WELL** require an external audit or third-party certification?

**Yes, WELL mandates third-party documentation review and on-site performance verification (PV) by authorized WELL Performance Testing Agents.** PV tests air/water quality, lighting, acoustics, and thermal comfort at ≥50% occupancy; two review rounds (preliminary/final) precede certification award.

How often should an assessment for **WELL** be performed?

**WELL requires recertification every three years, with annual reporting for select features like air quality monitoring.** Continuous monitoring pathways support ongoing compliance; full PV and documentation updates occur at recertification.

What are the consequences of non-compliance with **WELL**?

**Non-compliance results in certification denial, review fees for curative actions, and project delays.** No statutory penalties exist as WELL is voluntary, but failed PV may necessitate remediation, increased costs, or lower tiers; recertification lapses revoke status.

Can **WELL** be mapped to other international frameworks?

**Yes, IWBI provides official crosswalks mapping WELL features to frameworks like LEED.** These align overlapping requirements (e.g., air quality, materials), enabling streamlined dual certification and reduced documentation duplication.

What is the first step to begin implementing **WELL**?

**The first step is project enrollment/registration on the IWBI digital platform and scorecard development.** Identify applicable features, Preconditions, and target tier; conduct optional pre-testing for high-risk areas like air/water.

FDA 21 CFR Part 11 vs WELL

Q: What is the primary objective of **WELL**?

**The primary objective of WELL is to advance human health and well-being in buildings through performance-based design, operations, and policies across 10 core concepts: Air, Water, Nourishment, Light, Movement, Thermal Comfort, Sound, Materials, Mind, and Community.** Administered by the International WELL Building Institute (IWBI), WELL v2 requires meeting **24 mandatory Preconditions** and pursuing **102 optional Optimizations** to achieve certification tiers (Bronze: 40 points; Silver: 50 with 1 point/concept minimum; Gold: 60 with 2 points/concept; Platinum: 80 with 3 points/concept).

Standards Comparison

FDA 21 CFR Part 11

Mandatory

1997

FDA regulation for trustworthy electronic records and signatures

WELL

Voluntary

2014

Performance-based certification for occupant health in buildings

Quick Verdict

FDA 21 CFR Part 11 mandates electronic record trustworthiness for life sciences compliance, while WELL is a voluntary certification enhancing building occupant health. Pharma adopts Part 11 to avoid enforcement; real estate pursues WELL for productivity, ESG, and market differentiation.

Electronic Records

FDA 21 CFR Part 11

21 CFR Part 11 Electronic Records; Electronic Signatures

Cost

€€€€

Complexity

Medium

Implementation Time

12-18 months

Key Features

Establishes equivalency of electronic to paper records/signatures
Requires secure time-stamped audit trails for changes
Mandates unique multi-component electronic signatures
Differentiates controls for closed versus open systems
Enforces access authority and device checks

Building Health & Wellness

WELL

WELL Building Standard v2

Cost

€€€€

Complexity

High

Implementation Time

12-18 months

Key Features

10 core concepts for comprehensive health optimization
Mandatory preconditions with on-site performance verification
Point-based optimizations for tiered certification levels
Continuous monitoring pathways for ongoing compliance
Applicable to new and existing buildings universally

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

FDA 21 CFR Part 11 Details

What It Is

FDA 21 CFR Part 11 is a U.S. regulation establishing criteria for electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It applies to FDA-regulated industries using electronic systems for predicate-rule-required records, employing a risk-based approach narrowed by 2003 FDA guidance with enforcement discretion on certain elements.

Key Components

Subparts A-C cover scope, electronic records controls (§11.10 closed systems, §11.30 open systems), and signatures (§§11.50-11.300).
Core controls: validation, audit trails, access/authority/device checks, training, accountability policies, signature linking/uniqueness.
Built on ALCOA+ principles; no certification but inspection readiness required.

Why Organizations Use It

Ensures compliance with predicate rules, mitigates data integrity risks, avoids enforcement actions like warning letters. Provides strategic benefits: efficient digital transformation, faster inspections, improved quality investigations, stakeholder trust in life sciences.

Implementation Overview

Risk-based CSV lifecycle (GAMP5): scoping, validation (IQ/OQ/PQ), SOPs/training, supplier governance for SaaS. Applies to pharma/biotech/devices; phased 12-18 months, ongoing monitoring/change control.

WELL Details

What It Is

WELL Building Standard v2 is a performance-based certification framework administered by the International WELL Building Institute (IWBI). It focuses on designing, operating, and verifying buildings to optimize human health and well-being through evidence-based strategies. Its people-first approach emphasizes measurable indoor environmental quality outcomes via mandatory Preconditions and optional Optimizations.

Key Components

**10 core conceptsAir, Water, Nourishment, Light, Movement, Thermal Comfort, Sound, Materials, Mind, Community (plus Innovation).
24 Preconditions (pass/fail) and 102 Optimizations (point-earning).
Built on public health and building science research.
Certification tiers: Bronze (40 points), Silver (50), Gold (60), Platinum (80), with concept minimums at higher levels.

Why Organizations Use It

Drives occupant productivity, retention, and ESG metrics.
Complements LEED for health-focused differentiation.
Mitigates health risks and boosts rents/asset value.
Builds stakeholder trust via verified performance.

Implementation Overview

Phased: gap analysis, scorecard, documentation, on-site verification, operations.
Applies to new/existing buildings across sectors.
Requires third-party review/testing; recertification every 3 years.

Key Differences

Aspect	FDA 21 CFR Part 11	WELL
Scope	Electronic records/signatures trustworthiness	Building health/well-being performance outcomes
Industry	FDA-regulated life sciences, pharma	Real estate, offices, all building types
Nature	Mandatory FDA regulation, enforcement discretion	Voluntary performance certification standard
Testing	Risk-based system validation, audit trails	On-site performance verification, monitoring
Penalties	Warning letters, enforcement actions	Loss of certification, no legal penalties

Scope

FDA 21 CFR Part 11

Electronic records/signatures trustworthiness

WELL

Building health/well-being performance outcomes

Industry

FDA 21 CFR Part 11

FDA-regulated life sciences, pharma

WELL

Real estate, offices, all building types

Nature

FDA 21 CFR Part 11

Mandatory FDA regulation, enforcement discretion

WELL

Voluntary performance certification standard

Testing

FDA 21 CFR Part 11

Risk-based system validation, audit trails

WELL

On-site performance verification, monitoring

Penalties

FDA 21 CFR Part 11

Warning letters, enforcement actions

WELL

Loss of certification, no legal penalties

Frequently Asked Questions

Common questions about FDA 21 CFR Part 11 and WELL

FDA 21 CFR Part 11 FAQ

WELL FAQ

You Might also be Interested in These Articles...

Singapore PDPA Implementation Guide: Mastering Part 6A Breach Notification Thresholds and Timelines from Primary Statute

Master Singapore PDPA Part 6A breach notifications: statutory thresholds (risk of significant harm), 72-hour timelines, checklists, templates & frameworks. Comp

Your Compliance Command Center: How Modern Tools Orchestrate Cross-Departmental Adherence

Unlock your compliance command center with modern tools for real-time monitoring, automation & integrations across IT, HR, Legal & Finance. Slash non-compliance

CIS Controls v8.1, Operationalized: Top 10 Reasons Compliance Monitoring Software Accelerates Real-World Implementation

Operationalize CIS Controls v8.1 with compliance monitoring software. Turn checklists into dashboards, tickets, and audit-proof workflows. Top 10 reasons it acc

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Check out these other Gradum.io Standards Comparison Pages

NIST CSF vs Six Sigma

Explore NIST CSF vs Six Sigma: Cyber governance meets process excellence. Uncover differences, synergies for risk reduction & ops optimization. Elevate strategy now!

CMMI vs GDPR UK

Compare CMMI maturity models vs UK GDPR compliance: Boost process predictability and data security. Uncover synergies, gaps, and strategies for seamless IT integration now.

CMMC vs J-SOX

Compare CMMC vs J-SOX: DoD cybersecurity tiers for DIB vs Japan's ICFR rules. Master key differences, compliance paths, risks & strategies for global defense success.

FDA 21 CFR Part 11

WELL

Quick Verdict

FDA 21 CFR Part 11

Key Features

WELL

Key Features

Detailed Analysis

FDA 21 CFR Part 11 Details

What It Is

Key Components

Why Organizations Use It

Implementation Overview

WELL Details

What It Is

Key Components

Why Organizations Use It

Implementation Overview

Key Differences

Scope

Industry

Nature

Testing

Penalties

Frequently Asked Questions

FDA 21 CFR Part 11 FAQ

What is the primary objective of FDA 21 CFR Part 11?

Who is legally or professionally required to comply with FDA 21 CFR Part 11?

Does FDA 21 CFR Part 11 require an external audit or third-party certification?

How often should an assessment for FDA 21 CFR Part 11 be performed?

What are the consequences of non-compliance with FDA 21 CFR Part 11?

Can FDA 21 CFR Part 11 be mapped to other international frameworks?

What is the first step to begin implementing FDA 21 CFR Part 11?

WELL FAQ

What is the primary objective of WELL?

Who is legally or professionally required to comply with WELL?

Does WELL require an external audit or third-party certification?

How often should an assessment for WELL be performed?

What are the consequences of non-compliance with WELL?

Can WELL be mapped to other international frameworks?

What is the first step to begin implementing WELL?

You Might also be Interested in These Articles...

Singapore PDPA Implementation Guide: Mastering Part 6A Breach Notification Thresholds and Timelines from Primary Statute

Your Compliance Command Center: How Modern Tools Orchestrate Cross-Departmental Adherence

CIS Controls v8.1, Operationalized: Top 10 Reasons Compliance Monitoring Software Accelerates Real-World Implementation

Run Maturity Assessments with GRADUM

Check out these other Gradum.io Standards Comparison Pages

NIST CSF vs Six Sigma

CMMI vs GDPR UK

CMMC vs J-SOX